KATHERINE COFFEY: Open Payments
NPI 1518904135 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 77 payments from 19 companies in 2025. Trend: 2023 $812 · 2024 $987 · 2025 $1,489
Food & beverage: $1,489
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $246 |
| Novo Nordisk Inc | 10 | $212 |
| Amgen Inc. | 9 | $157 |
| ABBVIE INC. | 12 | $156 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Dexcom, Inc. | 4 | $90 |
| PFIZER INC. | 5 | $86 |
| Lilly USA, LLC | 5 | $78 |
| Abbott Laboratories | 3 | $62 |
| Corcept Therapeutics | 3 | $62 |
Products named: Ozempic, FARXIGA, AIRSUPRA, REXULTI, Dexcom G6 Transmitter, MOUNJARO, VRAYLAR, OTEZLA.
Industry payments across SC — which companies pay providers there.
